Law360 has this coverage of the Statement of Interest filed by the State of California in support of Herrera Purdy’s qui tam action against Allergan:
Calif. Backs Patent Atty’s Whistleblower Suit Against Allergan
California is supporting an attorney who filed a whistleblower lawsuit against Allergan Inc. alleging the pharmaceutical company fraudulently obtained patents to thwart generic competition and keep prices high, saying the attorney’s claims could have a big impact on how much insurers pay for drugs.
In a three-page statement of interest filed Monday, California said if patent attorney Zachary Silbersher’s complaint against Allergan, as well as a related suit against Valeant Pharmaceuticals, are successful, they could set an important precedent that would discourage drug companies from withholding or misrepresenting information related to patentability.
Read the rest of the article here.